Compare ICON & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ICON | RDHL |
|---|---|---|
| Founded | 2023 | 2009 |
| Country | Greece | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5M | 3.3M |
| IPO Year | 2023 | 2012 |
| Metric | ICON | RDHL |
|---|---|---|
| Price | $1.02 | $0.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.4K | ★ 2.5M |
| Earning Date | 02-24-2026 | 04-27-2026 |
| Dividend Yield | ★ 4754.20% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $22.33 | $381.91 |
| Revenue Next Year | $23.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.54 | $0.52 |
| 52 Week High | $4.23 | $2.79 |
| Indicator | ICON | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 52.31 | 34.51 |
| Support Level | $0.84 | N/A |
| Resistance Level | $1.08 | $1.07 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 65.22 | 0.00 |
Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users. The cargos carried by the company are Grains, Minerals, Iron Ore, Coal and Bauxite.
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.